Another Huntington’s Disease (HD) promising drug, pridopidine, a pill, could improve
quality of life for people by preserving their independence. HD often include slight disruptions in someone’s ability to perform day-to-day activities, such as handling their finances, remembering directions, and managing household chores.
HD clinicians often use a rating scale to measure “Total Functional Capacity” (TFC), which encompasses many aspects of someone’s capacity to live and function independently.
Prilenia’s drug, pridopidine, supports total functional capacity in people with HD. 
“PROOF-HD marks the first time in HD that we have had a study suggest benefit on multiple important clinical measures, including progression, cognition, and motor findings,” said North American investigator Andrew Feigin.
Prilenia eyes 2025 launch for Huntington’s drug pridopidine
We Can Never Lose Hope……
I’m a Huntington’s disease (HD) advocate,
President of the HDSA San Francisco Bay Area Chapter, a blogger and an author. Visit my website: https://theresecrutchermarin.com
